×
0 0 0.000695238736011256 0.000695238736011256 0.000695238736011256 0.000695238736011256 0.000695238736011256 0.000695238736011256
SEC impact report

Form 4 Y-mAbs Therapeutics, For: Jun 12 Filed by: Raskin Gregory S

Y-mAbs Therapeutics, Inc (YMAB)  More Company Research Source: SEC EDGAR
Last y-mabs therapeutics, inc earnings: 8/14 04:05 pm Check Earnings Report
Impact snapshot Event time: YMAB
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
YMAB alerts
from News Quantified
Opt-in for
YMAB alerts

from News Quantified
Opt-in for
YMAB alerts

from News Quantified